We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Contact Precautions for Patients With Multidrug-Resistant Pathogens—Reply

Daniel J. Morgan, MD, MS1; Keith S. Kaye, MD, MPH2; Daniel J. Diekema, MD, MS3
[+] Author Affiliations
1VA Maryland Healthcare System, Baltimore
2Wayne State University, Detroit, Michigan
3Division of Infectious Diseases, University of Iowa College of Medicine, Iowa City
JAMA. 2015;313(6):630. doi:10.1001/jama.2014.17448.
Text Size: A A A
Published online


In Reply We are aware of the large MOSAR-ICU quasi-experimental trial but disagree that it evaluated the addition of contact precautions to standard precautions. To our reading, the MOSAR study had 2 main phases: (1) comparing enhanced hand hygiene and chlorhexidine bathing with a baseline period and (2) comparing rapid vs conventional screening and isolation of patients with multidrug-resistant organisms, including MRSA and VRE.1 Dr Derde and colleagues imply that their trial compared standard precautions plus chlorhexidine bathing without contact precautions vs active surveillance for MRSA or VRE with contact precautions for those positive for MRSA or VRE.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




February 10, 2015
Lennie P. G. Derde, MD, PhD; Ben S. Cooper, PhD; Christian Brun-Buisson, MD, PhD
1Department of Intensive Care, University Medical Center Utrecht, Utrecht, the Netherlands
2Nuffield Department of Clinical Medicine, University of Oxford, Oxford, England
3Service de réanimation médicale, APHP GH Henri Mondor/ Université Paris Est-Créteil, Creteil, France
JAMA. 2015;313(6):629-630. doi:10.1001/jama.2014.17439.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...